Russia has named its first approved COVID-19 vaccine ‘Sputnik V’, in reference to the world’s first satellite, launched by the Soviet Union in 1957. Dmitriev said Russia and its foreign partners are already prepared to manufacture over 500 million doses of the vaccine per year in five countries, and the plan is to ramp up production capacity even higher.
The vaccine’s Phase 3 trial, involving thousands of participants, is set to take place in the UAE, Saudi Arabia, and several other countries. The Russian Health Ministry said in a statement that the vaccine is expected to provide immunity from the coronavirus for up to two years.
The World Health Organization and Russian health authorities are discussing possible WHO pre-qualification of the new vaccine, a WHO spokesman said Tuesday, adding that pre-qualification of any vaccine requires rigorous review and assessment.
- Russia approves 2nd coronavirus vaccine
- Russia’s COVID-19 vaccine pre-ordered by 20 nations for a billion doses
- President Putin says Russia is ‘first’ to develop coronavirus vaccine
- Vietnamese people put high trust in Russian Covid-19 vaccine
- Vietnam to buy 30 million doses of COVID-19 vaccine from UK
- Russia confirms Sputnik-V no side effects
- Covid 19 vaccine update Controversial Russia s Sputnik V and its availability
- Vladimir Putin to receive Russia s Sputnik V vaccine
- Key things about Russia s second COVID 19 vaccine EpiVacCorona
- Key things about Russia’s second COVID-19 vaccine EpiVacCorona